Pharma scrips rise marginally in September after 6 months of poor show (PharmaBiz)
Pharmaceutical shares experienced some support from investors during the last week of September 2007 despite appreciation of rupee against the US dollar.

Endo Pharmaceuticals and Vernalis Receive Action Letter From FDA on FROVA(R) Supplemental New Drug Application (Marketwire via Yahoo! Finance)
Endo Pharmaceuticals Inc., a wholly owned subsidiary of Endo Pharmaceuticals Holdings Inc., and Vernalis plc today announced that the U.S. Food and Drug Administration has identified deficiencies and asked for additional information pertaining to Endo's supplemental New Drug Application for FROVA 2.5 mg tablets in a "not approvable" letter. The sNDA is for the additional indication of FROVA ...

Sun Pharma arm gets FDA nod for hyperthyroidism drug (The Hindu)
CHENNAI: Sun Pharmaceutical Industries Ltd has informed the BSE that Detroit-based Caraco Pharmaceutical Laboratories, its US subsidiary, has obtained the US Food and Drug Administration 's (FDA) approval for its Abbreviated New Drug Application (ANDA) f or methimazole Tablets.